Finance

Lists
GANX:NASDAQ
Gain Therapeutics Inc
$1.67
-1.18%
(-0.020) 1D
$1.73
+3.59% (+0.060)
Pre-market
Closed: Oct 6, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
$1.70
High
$1.75
Low
$1.66
Mkt. cap
73.75M
Avg. vol.
421.34K
Volume
569.00
52-wk high
$4.34
52-wk low
$1.53
EPS
-$0.51
Beta
0.19
Shares outstanding
43.64M
No. of employees
21
Open
$1.70
High
$1.75
Low
$1.66
Mkt. cap
73.75M
Avg. vol.
421.34K
Volume
569.00
52-wk high
$4.34
52-wk low
$1.53
EPS
-$0.51
Beta
0.19
Shares outstanding
43.64M
No. of employees
21
News stories
From web sources and news partners
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current $1.67
$8.00 (+379.04%)
Average
$7.20 (+331.14%)
Lowest
$5.00 (+199.40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Shrader
BTIG
Buy
Maintained
$5.00
+199.4%
10/05/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$8.00
+379%
10/05/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$7.00
+319.2%
10/01/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$8.00
+379%
08/18/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$8.00
+379%
08/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps